Safety study of SAL0140 in healthy Chinese adults
Treatments studied
Part of Heart & circulation clinical trials.
This study tests the safety and how the body handles a new medicine (SAL0140) in healthy people. It helps doctors find the right dose and check for side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult between 18 and 65 years old.
- Your weight and body mass index (BMI) must be within a certain range.
- You cannot have used certain medications, supplements, or herbal remedies in the past 14 days.
- You must not have a history of certain heart conditions or low blood pressure upon standing.
- You cannot smoke, drink too much alcohol or caffeine, or donate blood for a period before and during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called SAL0140 for people whose high blood pressure is not controlled by current treatments. It may help lower blood pressure when other medications haven't worked well enough.
This study checks if taking the experimental drug with food changes how it works in the body. It helps decide the best way to take the drug in future studies.
This early-stage study tests a new investigational drug called QLS1410 in healthy adults and people with mild high blood pressure. The goal is to see how the drug works and if it is safe.
This study tests a new medication called SAL0167, which may help lower cholesterol, in healthy volunteers. It is a first-in-human study, meaning it looks at safety and how your body handles the drug, so it may not directly benefit your health but helps in developing a potential treatment for high cholesterol.
This study tests a new medicine, SAL0140, at different doses to see if it can help people with chronic kidney disease. It may reduce protein in the urine, which is a sign of kidney damage.
This trial tests a new medicine, SAL0140, for people with primary aldosteronism, a condition where the adrenal glands make too much aldosterone, causing high blood pressure. The study aims to see if the drug can lower blood pressure and improve health.
Hear when a new Uncontrolled Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.